期刊
NEUROBIOLOGY OF AGING
卷 35, 期 9, 页码 1973-1981出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2014.04.006
关键词
Alzheimer's disease; Amyloid; Imaging biomarkers; Mild cognitive impairment
资金
- Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
- National Institute on Aging
- National Institute of Biomedical Imaging and Bioengineering
- Canadian Institutes of Health Research
- NIH [P30 AG010129, K01 AG030514]
The goal of the present study was to determine the earliest patterns of hypometabolism and atrophy in the development of Alzheimer's disease (AD). Stages of AD were defined by positron emission tomography imaging evidence of cortical amyloid pathology in addition to cognitive criteria. Subjects for the study were selected from the Alzheimer's Disease Neuroimaging Initiative database and divided into 4 groups: cognitively normal (CN) amyloid negative (A beta-) elderly subjects (n = 36), CN amyloid-positive (A beta+) (n = 21), early mild cognitive impairment A beta+ (n 65), and late mild cognitive impairment A beta+ (n = 23) subjects. Region of interestebased (primary) and voxel-based (secondary) analyses were used to assess gray matter hypometabolism, quantified by [18F] fluorodeoxyglucose-positron emission tomography, and decrease in gray matter volume and cortical thickness was measured by magnetic resonance imaging. Region of interest- and voxel-based analyses showed significant hypometabolism but not atrophy in CN A beta+ subjects compared with CN A beta- subjects. The results suggest that hypometabolism exceeds atrophy in preclinical AD, supporting the notion that amyloid load may affect synaptic activity, leading to synaptic loss and subsequent neuronal loss. (C) 2014 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据